- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Clears Siemens Mammography System
Siemens Healthcare has received FDA clearance for their MAMMOMAT Inspiration Prime Edition lower dose mammography system.
Siemens Healthcare has received FDA clearance for their MAMMOMAT Inspiration Prime Edition mammography system, which lowers radiation dose by up to 30 percent, the company said.
This latest MAMMOMAT system reduces dose by replacing the standard scatter radiation grid with a new algorithm for progressive image reconstruction, according to Siemens. The algorithm can identify scatter-causing structures and calculating a corrected image. This may enable the complete use of primary radiation to achieve lower dose, the company said.
The design of the MAMMOMAT Inspiration Prime Edition obviates the need for a grid, the company said, and lower doses compared to the predecessor model are needed for high-quality images. This edition is based the MAMMOMAT Inspiration platform which has been used since 2007.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
